🇺🇸 FDA
Patent

US 8557839

Fused ring azadecalin glucocorticoid receptor modulators

granted A61PA61P13/12A61P17/02

Quick answer

US patent 8557839 (Fused ring azadecalin glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P13/12, A61P17/02, A61P19/00, A61P19/02